Showing results (511-520 of 991) with videos related to
Sort By:
Pageof 100
Therapeutic Advances in Respiratory Disease|April 23, 2011
NVA237, a long-acting muscarinic antagonist, as an emerging therapy for chronic obstructive pulmonary diseaseClaus Vogelmeier, Donald BanerjiTherapeutic Advances in Respiratory Disease|May 19, 2011
Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?Michel Aubier, John Haughney, Olof Selroos, et al.Therapeutic Advances in Respiratory Disease|September 30, 2015
Lumacaftor and ivacaftor in the management of patients with cystic fibrosis: current evidence and future prospectsKelly Kuk, Jennifer L Taylor-CousarTherapeutic Advances in Respiratory Disease|January 10, 2016
Comparative efficacy of fixed-dose combinations of long-acting muscarinic antagonists and long-acting β2-agonists: a systematic review and network meta-analysisMax Schlueter, N Gonzalez-Rojas, Michael Baldwin, et al.Therapeutic Advances in Respiratory Disease|January 10, 2016
The role of NIV in chronic hypercapnic COPD following an acute exacerbation: the importance of patient selection?Marieke L Duiverman, Wolfram Windisch, Jan H Storre, et al.Therapeutic Advances in Respiratory Disease|April 10, 2016
Treatment response according to small airway phenotypes: a real-life observational studyKatharina Marth, Monica Spinola, Judith Kisiel, et al.Therapeutic Advances in Respiratory Disease|December 31, 2014
Indwelling pleural catheters for pleural effusions associated with end-stage renal disease: a case seriesRajini Potechin, Kayvan Amjadi, Nadim SrourTherapeutic Advances in Respiratory Disease|May 18, 2019
Aclidinium bromide in fixed-dose combination with formoterol fumarate in the management of COPD: an update on the evidence baseAnthony D D'Urzo, Dave Singh, James F Donohue, et al.Therapeutic Advances in Respiratory Disease|April 9, 2019
Fiducial marker placement with electromagnetic navigation bronchoscopy: a subgroup analysis of the prospective, multicenter NAVIGATE studyMark R Bowling, Erik E Folch, Sandeep J Khandhar, et al.Therapeutic Advances in Respiratory Disease|July 18, 2018
Addition of hyaluronic acid improves tolerance to 7% hypertonic saline solution in bronchiectasis patientsLuis Máiz, Rosa M Girón, Eva Prats, et al.Pageof 100